Literature DB >> 18794401

Prevention of atrial fibrillation with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.

Oliver Adam1, Hans-Ruprecht Neuberger, Michael Böhm, Ulrich Laufs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18794401     DOI： 10.1161/CIRCULATIONAHA.107.760892

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  19 in total

1.  High-sensitivity C-reactive protein, statin therapy, and risks of atrial fibrillation: an exploratory analysis of the JUPITER trial.

Authors:  Jessica M Peña; Jean MacFadyen; Robert J Glynn; Paul M Ridker
Journal:  Eur Heart J       Date:  2011-12-20       Impact factor: 29.983

Review 2.  Early management of atrial fibrillation: from imaging to drugs to ablation.

Authors:  Ashok J Shah; Xingpeng Liu; Amir S Jadidi; Michel Haïssaguerre
Journal:  Nat Rev Cardiol       Date:  2010-04-27       Impact factor: 32.419

3.  Do Statins Reduce Atrial Fibrillation After Coronary Artery Bypass Grafting?

Authors:  Anil Paturi; Aman Shukla; George Ebra; Viet Nguyen; Steven Borzak
Journal:  J Atr Fibrillation       Date:  2011-07-15

4.  Rac1 and connective tissue growth factor. The missing link between atrial remodeling and the pathogenesis of atrial fibrillation?

Authors:  James K Liao
Journal:  J Am Coll Cardiol       Date:  2010-02-02       Impact factor: 24.094

Review 5.  Mechanisms of new-onset atrial fibrillation complicating acute coronary syndrome.

Authors:  J Wang; Y-M Yang; J Zhu
Journal:  Herz       Date:  2014-10-30       Impact factor: 1.443

6.  Blood lipid levels, lipid-lowering medications, and the incidence of atrial fibrillation: the atherosclerosis risk in communities study.

Authors:  Faye L Lopez; Sunil K Agarwal; Richard F Maclehose; Elsayed Z Soliman; A Richey Sharrett; Rachel R Huxley; Suma Konety; Christie M Ballantyne; Alvaro Alonso
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-01-06

7.  Hypercholesterolemia induces up-regulation of KACh cardiac currents via a mechanism independent of phosphatidylinositol 4,5-bisphosphate and Gβγ.

Authors:  Wu Deng; Anna N Bukiya; Aldo A Rodríguez-Menchaca; Zhe Zhang; Clive M Baumgarten; Diomedes E Logothetis; Irena Levitan; Avia Rosenhouse-Dantsker
Journal:  J Biol Chem       Date:  2011-12-15       Impact factor: 5.157

8.  Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop.

Authors:  Emelia J Benjamin; Peng-Sheng Chen; Diane E Bild; Alice M Mascette; Christine M Albert; Alvaro Alonso; Hugh Calkins; Stuart J Connolly; Anne B Curtis; Dawood Darbar; Patrick T Ellinor; Alan S Go; Nora F Goldschlager; Susan R Heckbert; José Jalife; Charles R Kerr; Daniel Levy; Donald M Lloyd-Jones; Barry M Massie; Stanley Nattel; Jeffrey E Olgin; Douglas L Packer; Sunny S Po; Teresa S M Tsang; David R Van Wagoner; Albert L Waldo; D George Wyse
Journal:  Circulation       Date:  2009-02-03       Impact factor: 29.690

Review 9.  Primary and secondary prevention of atrial fibrillation with statins and polyunsaturated fatty acids: review of evidence and clinical relevance.

Authors:  Irene Savelieva; Antonios Kourliouros; John Camm
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-11-25       Impact factor: 3.000

Review 10.  Statin therapy may influence the incidence of postoperative atrial fibrillation: what is the evidence?

Authors:  Srdjan Saso; Joshua A Vecht; Christopher Rao; Aristotle Protopapas; Hutan Ashrafian; Daniel Leff; Ara Darzi; Thanos Athanasiou
Journal:  Tex Heart Inst J       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.